BIOMARIN PHARMACEUTICAL INC Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2014-12-23: Form 8-K; Exhibit 10.1; Description BioMarin Pharmaceutical Inc. 2014 Inducement Plan.
- 2014-11-26: Form 8-K; Exhibit 10.3; Description Convertible Promissory Note, dated as of November 26, 2014, between Prosensa Holding N.V. and BioMarin Falcons B.V..
- 2014-11-26: Form 8-K; Exhibit 10.2; Description Form of Tender and Support Agreement.
- 2014-11-26: Form 8-K; Exhibit 10.1; Description Form of Contingent Value Rights Agreement.
| Filed | Form | Exhibit | Description |
|---|
| 2014-12-23 | 8-K | 10.1 | BioMarin Pharmaceutical Inc. 2014 Inducement Plan |
|---|
| 2014-11-26 | 8-K | 10.3 | Convertible Promissory Note, dated as of November 26, 2014, between Prosensa Holding N.V. and BioMarin Falcons B.V. |
|---|
| 2014-11-26 | 8-K | 10.2 | Form of Tender and Support Agreement |
|---|
| 2014-11-26 | 8-K | 10.1 | Form of Contingent Value Rights Agreement |
|---|
| 2014-10-28 | 10-Q | 10.1 | Asset Purchase Agreement, between BioMarin Pharmaceutical Inc., BioMarin GALNS Ltd. and Regeneron Ireland dated July 29, 2014. |
|---|
| 2014-10-14 | 8-K | 10.2 | Amended and Restated Nonqualified Deferred Compensation Plan effective October 7, 2014 |
|---|
| 2014-10-14 | 8-K | 10.1 | Amended and Restated Severance Plan and Summary Plan Description effective October 7, 2014 |
|---|
| 2014-06-10 | 8-K | 10.1 | AMENDED AND RESTATED 2006 EMPLOYEE STOCK. PURCHASE PLAN |
|---|
| 2014-05-02 | 10-Q | 10.1 | Amended and Restated BioMarin Pharmaceutical Inc., Non-Qualified Defined Compensation Plan, as adopted on December 1, 2005, as amended and restated on July 1, 2009 and as further amended on December 19, 2013. |
|---|
| 2014-02-26 | 10-K | 10.68 | Contract of Purchase and Sale and Joint Escrow Instructions, dated December 17, 2013, for the San Rafael Corporate Center, by and among BioMarin Pharmaceutical Inc., through its wholly-owned subsidiary, California Corporate Center Acquisition, LLC, SR Corporate Center Phase One, LLC, and SR Corporate Center Phase Two. |
|---|